Early Phase 1 Crohn's Disease and Colitis Trial, Recruiting NCT07273188 Sponsor: Mayo Clinic Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Early Phase 1 Crohn's Disease and Colitis Trial, Recruiting

NCT07273188
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Crohn's disease affecting the small bowel
  • People who have had a specific type of bowel imaging scan (either an MRI or CT scan of the bowel) within the last 3 months, whether for research or routine care
  • People who are 18 years of age or older
  • People whose Crohn's disease has been diagnosed by a gut specialist (gastroenterologist)
  • People who are willing to undergo a special type of scan called a 68Ga-FAPI-46 PET/CT scan
  • People who are able to understand what the trial involves and are willing to sign a written consent form

Who may not be able to join:

  • People who are pregnant or currently breastfeeding
  • People who have had an allergic reaction or sensitivity to any of the ingredients in the 68Ga-FAPI-46 scan substance (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: David J Bartlett, Mayo Clinic

Phone: 507-266-0111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Registry
ClinicalTrials.gov
Start date
26 January 2026
Est. completion
28 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Completion of PET/CT with Ga68-FAPI-46 by all participants; Number of participants completing PET/CT with Ga68-FAPI-46

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov